276 related articles for article (PubMed ID: 16354223)
1. The efficacy of two different lipid-based amphotericin B in neonatal Candida septicemia.
Cetin H; Yalaz M; Akisu M; Hilmioglu S; Metin D; Kultursay N
Pediatr Int; 2005 Dec; 47(6):676-80. PubMed ID: 16354223
[TBL] [Abstract][Full Text] [Related]
2. Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex.
Knoppert DC; Salama HE; Lee DS
Ann Pharmacother; 2001 Sep; 35(9):1032-6. PubMed ID: 11573851
[TBL] [Abstract][Full Text] [Related]
3. Renal tolerance with the use of intralipid-amphotericin B in low-birth-weight neonates.
Friedlich PS; Steinberg I; Fujitani A; deLemos RA
Am J Perinatol; 1997 Aug; 14(7):377-83. PubMed ID: 9263555
[TBL] [Abstract][Full Text] [Related]
4. Effects of fluid and electrolyte management on amphotericin B-induced nephrotoxicity among extremely low birth weight infants.
Holler B; Omar SA; Farid MD; Patterson MJ
Pediatrics; 2004 Jun; 113(6):e608-16. PubMed ID: 15173544
[TBL] [Abstract][Full Text] [Related]
5. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B lipid complex for neonatal invasive candidiasis.
Adler-Shohet F; Waskin H; Lieberman JM
Arch Dis Child Fetal Neonatal Ed; 2001 Mar; 84(2):F131-3. PubMed ID: 11207232
[TBL] [Abstract][Full Text] [Related]
7. Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
Walsh TJ; Seibel NL; Arndt C; Harris RE; Dinubile MJ; Reboli A; Hiemenz J; Chanock SJ
Pediatr Infect Dis J; 1999 Aug; 18(8):702-8. PubMed ID: 10462340
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates.
Manzoni P; Galletto P; Rizzollo S; Franco C; Gallo E; Antonucci R; Fanos V; Farina D
Early Hum Dev; 2012 May; 88 Suppl 2():S86-91. PubMed ID: 22633524
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B (AmBisome) in the treatment of neonatal candidiasis in very low birth weight infants.
Juster-Reicher A; Leibovitz E; Linder N; Amitay M; Flidel-Rimon O; Even-Tov S; Mogilner B; Barzilai A
Infection; 2000; 28(4):223-6. PubMed ID: 10961528
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B treatment for neonatal fungal infections.
Scarcella A; Pasquariello MB; Giugliano B; Vendemmia M; de Lucia A
Pediatr Infect Dis J; 1998 Feb; 17(2):146-8. PubMed ID: 9493812
[TBL] [Abstract][Full Text] [Related]
11. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
[TBL] [Abstract][Full Text] [Related]
12. Candida albicans meningitis in a 27 weeks premature infant treated with liposomal amphotericin-B (AmBisome).
Jarløv JO; Born P; Bruun B
Scand J Infect Dis; 1995; 27(4):419-20. PubMed ID: 8658084
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience.
Lister J
Eur J Haematol Suppl; 1996; 57():18-23. PubMed ID: 8706812
[TBL] [Abstract][Full Text] [Related]
14. Experience with caspofungin in the treatment of persistent fungemia in neonates.
Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
[TBL] [Abstract][Full Text] [Related]
15. A comparison of AmBisome to amphotericin B for treatment of systemic candidiasis in very low birth weight infants.
Jeon GW; Koo SH; Lee JH; Hwang JH; Kim SS; Lee EK; Chang W; Chang YS; Park WS
Yonsei Med J; 2007 Aug; 48(4):619-26. PubMed ID: 17722233
[TBL] [Abstract][Full Text] [Related]
16. [Sepsis by Candida in VLBW neonates: therapy with liposomal Amphotericin B].
Occhipinti E; Caravello T; Ciminello N; Di Pietro A; Lima G; Machì A; Raia GM; Scarfia MF; Spinto C; Vaccaro PG; Rizzo A
Pediatr Med Chir; 2004; 26(1):57-60. PubMed ID: 15529814
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
Wiley JM; Seibel NL; Walsh TJ
Pediatr Infect Dis J; 2005 Feb; 24(2):167-74. PubMed ID: 15702047
[TBL] [Abstract][Full Text] [Related]
18. Disseminated fungemia due to Candida krusei with cutaneous lesions and successful treatment by amphotericin B lipid complex and catheter removal: a case report.
Hourez R; Gillard PH; Mariat P; Aoun M
Int J Infect Dis; 2002 Dec; 6(4):326-8. PubMed ID: 12725216
[No Abstract] [Full Text] [Related]
19. Development of candidemia on caspofungin therapy: a case report.
Cheung C; Guo Y; Gialanella P; Feldmesser M
Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
[TBL] [Abstract][Full Text] [Related]
20. Worsening of endogenous Candida albicans endophthalmitis during therapy with intravenous lipid complex amphotericin B.
Virata SR; Kylstra JA; Brown JC; Wohl DA; Cohen MS
Clin Infect Dis; 1999 May; 28(5):1177-8. PubMed ID: 10452666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
